If you don't remember your password, you can reset it by entering your email address and clicking the Reset Password button. You will then receive an email that contains a secure link for resetting your password
If the address matches a valid account an email will be sent to __email__ with instructions for resetting your password
The Post Mortem-Interval (PMI), also known as time since death, is of relevance for forensic routine casework and serves primarily as the basis for the determination of the time that has passed since the time of death. The existing, “classical” approaches are characterised by certain limitations because they are predominantly based on morphological examinations.
The present study deals with the assessment of two molecular messengerRNA-markers in different kinds post-mortem human specimens concerning their ability to use them for the estimation of the time of death. Moreover, a comparison between carefully selected endogenous and one exogenous reference marker for the normalisation of the gene expression data as relevant for accurate PMI estimation is drawn.
The evaluation showed that the used approach is methodologically useful but on consideration of the achieved results it was only possible to determine slightly meaningful tendencies. The tested exogenous reference marker was not suitable for sufficient data normalisation whereas the endogenous reference markers showed a stable expression. However, it was not possible to recognise a specific expression level of the genes within a PMI group when endogenous reference markers were used.
The Post Mortem-Interval (PMI), also known as time since death, is of prime forensic relevance and serves primarily as the basis for the determination of the time that has passed since the time of death. It used to determine the time of death in order to reconstruct the course of events since the time of the crime can be narrowed down as well as in case of homicides, that claimed more than one victim, a statement about the sequence of the deaths can be made [
]. In addition, a determination of the PMI can contribute to the verification of alibis and thus, to the delimitation of suspects.
However, the existing, “classical” approaches are characterised by certain limitations because they are predominantly based on morphological examinations. Hence, they only work for the early PMI.
Therefore, it was tried to establish a new method for the PMI determination by means of a RNA-based gene expression analysis. Numerous studies in this field showed that messengerRNA (mRNA) in postmortal human specimens is stable enough to serve as biomarker for the estimation of PMI [
In the present study, the gene expression analysis was performed by means of quantitative real-time polymerase chain reaction (qPCR) and subsequent normalisation of the data against an external reference RNA or various mRNA, microRNA (miRNA) and small nucleolarRNA (snoRNA), respectively.
2. Material & methods
2.1 Sample collective
Tissue samples from the brain, heart muscle, spleen, adrenal gland, skeletal muscle and blood of female (N = 11) and male (N = 10) deceased with exactly known PMI (death – autopsy of the dead body) were taken during judicially ordered autopsies (see Table 1).
Table 1Overview of the sample collective.
SPMI (♀ N = 5; ♂ N = 5)
MPMI (♀ N = 5; ♂ N = 5)
LPMI (♀ N = 1)
SPMI = Short PMI (2–4 days), MPMI = Medium PMI (5–7 days), LPMI = Long PMI (10 days).
Min. = Minimum; Max. = Maximum; BMI = Body Mass Index.
], was used. The search resulted in following choice: PHF1, USF2 (both mRNA for HIF1A), KIAA0586, ZNF74 (both mRNA for PER3), RNU24 and hsa-miR-191-5p (snoRNA and miRNA for HIF1A and PER3).
Fig. 1 shows the workflow used for working with the exogenous as well as the endogenous reference markers.
2.6 Data analysis
All obtained quantification cycle (Cq)-values were baseline corrected by means of the “LinRegPCR” analysis program v2017.1 (Heart Failure Research Center, Amsterdam, the Netherlands) and efficiency corrected as well as normalised utilising the “GenEx” software v6 (MultiD Analyses AB, Goteborg, Sweden). The thereby determined ΔCq-values (ΔCq = Cq (mRNA) – Cq (reference)) were rated as unspecific amplification if >35 and excluded from further analysis.
The RNA concentrations noticeably varied between the tissues and the blood, respectively. However, all samples yielded enough RNA for subsequent analyses.
The evaluation of the achieved results for the exogenous reference marker showed that it was not suitable for sufficient data normalisation. The measured spike gene expression noticeably fluctuated between the different samples but also within the tissue types and the blood, respectively.
For the endogenous reference markers stable expression values were obtained. However, it was not possible to recognise a specific expression level of the genes within a PMI group.
4. Discussion & conclusion
Although the RNA concentrations yielded noticeably different results for the used post-mortem human specimens, all are suitable for mRNA profiling and no difference between the RNA yield and the PMI was observed.
Based on the results for the exogenous reference marker it can be seen that it did not fulfil the precondition for a suitable reference marker. Therefore, it is not recommended to use the TATAA Universal RNA Spike I for data normalisation in gene expression analysis.
The tested endogenous reference markers were suitable for data normalisation. It was proven that these kinds of endogenous reference markers should be chosen as references for gene expression analysis. For further studies it will be tried to not only use PMI marker-specific but also tissue-specific reference markers to thereby possibly achieve PMI-specific expression levels within a PMI group.
All in all, the presented moleculargenetic approach for PMI-determination turned out to be methodologically useful but under consideration of the achieved results as less informative. Nonetheless, the in literature described potential of the tested PMI marker [